Criteo S.A. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Criteo S.A. ("Lux Criteo") on August 5, 2026. The filing announces the entry into a definitive agreement to restructure the company's domicile through a cross-border merger.
Key Financial Metrics
This filing does not contain financial performance data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a corporate restructuring transaction.
Material Changes and Transaction Details
On August 5, 2026, Lux Criteo entered into an Agreement and Plan of Merger with its wholly owned Delaware subsidiary, Criteo Holdings, Inc. ("U.S. Criteo"). The key terms of the proposed "U.S. Merger" include:
- Surviving Entity: Lux Criteo will merge into U.S. Criteo, which will become the surviving corporation.
- Effective Time: The merger is scheduled to occur at 12:00:01 a.m. New York City time on January 1, 2027, subject to conditions.
- Share Exchange: Each outstanding ordinary share of Lux Criteo will be automatically cancelled and exchanged for one share of U.S. Criteo common stock on a one-to-one basis.
- Equity Awards: Existing equity-based compensation plans (warrants, RSUs) will be assumed by U.S. Criteo and converted to awards of its common stock on a one-to-one basis.
- Corporate Governance: The directors and officers of Lux Criteo will become the directors and officers of U.S. Criteo immediately following the Effective Time.
Conditions, Risks, and Outlook
The completion of the U.S. Merger is subject to several material conditions, including:
- Approval by the requisite vote of Lux Criteo shareholders.
- Effectiveness of the Registration Statement on Form S-4.
- Approval for listing U.S. Criteo common stock on a nationally recognized U.S. securities exchange.
- Obtaining all necessary governmental consents and authorizations.
- Termination rights: The parties may mutually decide to terminate the agreement at any time prior to the Effective Time.
Risks and Contingencies: The filing includes extensive forward-looking statements and disclaimers. Risks include failure to obtain shareholder approval, regulatory hurdles, inability to list on a U.S. exchange, disruption to operations and relationships, and changes in the marketing industry or data privacy regulations. The filing explicitly states that actual outcomes may differ materially from projections.
Investor Verification Checklist
- Verify the status of the Registration Statement on Form S-4 filed by U.S. Criteo for the proxy statement/prospectus.
- Confirm the date and details of the special meeting of Lux Criteo shareholders required to approve the merger.
- Review the definitive proxy statement/prospectus for detailed risk factors and the specific U.S. exchange selected for listing.
- Monitor for any regulatory approvals or legal proceedings that could delay or prevent the January 1, 2027, Effective Time.